<h4>Introduction</h4>Activation of interferon (IFN) pathways is a central mechanism in the pathogenesis of Sjögren's disease (SjD) and systemic lupus erythematosus (SLE). This evidence concerns the gene IFNA1 and systemic lupus erythematosus.